ERBA DIAGNOSTICS
ERB
ERB was delisted on the 29th of September, 2016.
0 hedge funds and large institutions have $0 invested in ERBA DIAGNOSTICS in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $2K → $0 (-$2K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VIA
Vantage Investment Advisors
State College,
Pennsylvania
|
-$2K |
ERB Hedge Fund Activity: Q4 2017 in Review
0 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in ERBA DIAGNOSTICS (ERB) for Q4 2017, worth a combined $0 — down 100% from $2K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ERB and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Vantage Investment Advisors, exiting entirely with an estimated $2K sold.
- 0 institutional investors held ERBA DIAGNOSTICS (ERB) as of Q4 2017, down from 1 in Q3 2017.
- Funds reported $0 of ERBA DIAGNOSTICS stock for Q4 2017, down 100% quarter-over-quarter.
- 0 funds opened new ERBA DIAGNOSTICS positions in Q4 2017 and 1 closed out, a net change of -1 holder.
- The largest ERBA DIAGNOSTICS seller in Q4 2017 was Vantage Investment Advisors, an estimated $2K sold.
Based on aggregated 13F filings for Q4 2017.